IDO1 and ovarian neoplasm: In EOC patients, elevated IDO1 expression correlated with a lower Trp:Kyn ratio in the ovarian tumor microenvironment (11), reduced CD8+ TIL frequency (12), poor prognosis (13, 14), and suppression of T cell responses (15).